Singapore markets close in 2 hours 44 minutes

Kymera Therapeutics, Inc. (KYMR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
35.70+0.38 (+1.08%)
At close: 04:00PM EDT
35.70 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151616
Avg. Estimate-0.68-0.74-2.84-3.09
Low estimate-0.81-1.02-3.71-4.24
High estimate-0.4-0.48-1.92-1.33
Year ago EPS-0.67-0.9-2.52-2.84
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts16141616
Avg. Estimate12.55M10.8M52.16M67.44M
Low estimate4.2M4.2M15.2M14.4M
High estimate28.5M22.18M105.3M129.1M
Year ago sales14.06M4.73M78.59M52.16M
Sales growth (year/est)-10.70%128.40%-33.60%29.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.64-0.64-0.4-0.73
Actual EPS-0.67-0.9-0.25-0.69
Difference-0.03-0.260.150.04
Surprise %-4.70%-40.60%37.50%5.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.68-0.74-2.84-3.09
7 days ago-0.68-0.74-2.84-3.09
30 days ago-0.77-0.84-3.07-3.23
60 days ago-0.77-0.84-3.07-3.23
90 days ago-0.78-0.87-3.15-3
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days11111511
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKYMRIndustrySector(s)S&P 500
Current qtr.-1.50%N/AN/AN/A
Next qtr.17.80%N/AN/AN/A
Current year-12.70%N/AN/AN/A
Next year-8.80%N/AN/AN/A
Next 5 years (per annum)1.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A